Evidence mapPaperPMID 39752155Full record

SynthesisJAMA network open2025

Mortality Risk Prediction Models for People With Kidney Failure: A Systematic Review.

Faisal Jarrar, Meghann Pasternak, Tyrone G Harrison, Matthew T James, Robert R Quinn, Ngan N Lam, Maoliosa Donald, Meghan Elliott, Diane L Lorenzetti, Giovanni Strippoli and 4 more

Abstract readSystematic Review
In one paragraph

Synthesis in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Faisal JarrarDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Meghann PasternakDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Tyrone G HarrisonDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Matthew T JamesDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Robert R QuinnDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ngan N LamDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Maoliosa DonaldDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Meghan ElliottDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Diane L LorenzettiLibraries and Cultural Resources, University of Calgary, Calgary, Alberta, Canada.
Giovanni StrippoliDepartment of Precision and Regenerative Medicine and Jonian Area, University of Bari, Bari, Italy.
Ping LiuDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Simon SawhneyAberdeen Centre for Health Data Science, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
Thomas Alexander GerdsDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Pietro RavaniDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Funding

CIHR
6 · The paper itself

Abstract

Importance: People with kidney failure have a high risk of death and poor quality of life. Mortality risk prediction models may help them decide which form of treatment they prefer. Objective: To systematically review the quality of existing mortality prediction models for people with kidney failure and assess whether they can be applied in clinical practice. Evidence Review: MEDLINE, Embase, and the Cochrane Library were searched for studies published between January 1, 2004, and September 30, 2024. Studies were included if they created or evaluated mortality prediction models for people who developed kidney failure, whether treated or not treated with kidney replacement with hemodialysis or peritoneal dialysis. Studies including exclusively kidney transplant recipients were excluded. Two reviewers independently extracted data and graded each study at low, high, or unclear risk of bias and applicability using recommended checklists and tools. Reviewers used the Prediction Model Risk of Bias Assessment Tool and followed prespecified questions about study design, prediction framework, modeling algorithm, performance evaluation, and model deployment. Analyses were completed between January and October 2024. Findings: A total of 7184 unique abstracts were screened for eligibility. Of these, 77 were selected for full-text review, and 50 studies that created all-cause mortality prediction models were included, with 2 963 157 total participants, who had a median (range) age of 64 (52-81) years. Studies had a median (range) proportion of women of 42% (2%-54%). Included studies were at high risk of bias due to inadequate selection of study population (27 studies [54%]), shortcomings in methods of measurement of predictors (15 [30%]) and outcome (12 [24%]), and flaws in the analysis strategy (50 [100%]). Concerns for applicability were also high, as study participants (31 [62%]), predictors (17 [34%]), and outcome (5 [10%]) did not fit the intended target clinical setting. One study (2%) reported decision curve analysis, and 15 (30%) included a tool to enhance model usability. Conclusions and Relevance: According to this systematic review of 50 studies, published mortality prediction models were at high risk of bias and had applicability concerns for clinical practice. New mortality prediction models are needed to inform treatment decisions in people with kidney failure.

Indexed as

Renal InsufficiencyHumansRisk Assessment

Identifiers

PMID39752155
PMCPMC11699530

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.